ChinaBio^® LLC and EBD Group will host their fouth ChinaBio^® Partnering Forum in China to meet the needs of biotech and pharma companies as well as developers of early stage technology looking for funding and strategic partnerships. The 2011 event brought together 658 attendees from over 358 companies and 25 countries for two days of intense partnering. Participants included most of the major pharma as well as many of China’s biopharmaceutical companies and CROs/CMOs. Join us to meet global pharmas, China biotech companies, VCs and others interested in funding or developing technologies in China.

The China Healthcare Investment Conference is the premier event of its kind in China. As the leading event of the year focusing on rapidly-growing Chinese healthcare companies, the Conference will be a great opportunity to meet with emerging companies, industry leaders, key governmental officials and avid investors from China and the West. The conference brings together those company executives, entrepreneurs, investors, services providers and government officials interested in and committed to the development of the China healthcare industry.

Please join 200 biotech and pharmaceutical CEOS at the 2012 Shanghai CEO conference at the Peninsula Shanghai, March 28th and 29th, 2012. Current Shanghai CEO co-hosts include: Paul Bolno (GlaxoSmithKline), Nancy Chang (OrbiMed), Chun-Lin Chen (Medicilon), Li Chen (Hua Medicine), Michelle Dipp (OvaScience), Samantha Du, Robert Forrester (Verastem), Ge Li (WuXi Pharma), Joel Marcus (Alexandria), Robert Nelsen (ARCH Venture Partners), Paul Schimmel (Scripps), Goro Takeda, Christoph Westphal (Verastem), Steve Yang (Astrazeneca), and Jingwu Zang (GSK). Please see the preliminary agenda below and register at: